BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cigna Launches World's First Voice-Activated Stress Test

'Cigna StressWaves Test' powered by Ellipsis Health's advanced AI technology First and only stress analysis model to detect both acoustic and semantic p...

August 10, 2021 | News

South Korea to Expand patient access to incision-free Focused Ultrasound treatment

Insightec®, a global healthcare company focused on creating the next generation of patient care, announced Seoul National University Ho...

August 09, 2021 | News

HUAWEI, Aligns With PLANO to Tackle the Global Problem of Myopia

Huawei Technologies Co. Ltd. (hereinafter, Huawei) and Plano Pte. Ltd. (hereinafter, Plano) today announced their partnership to address the global problem...

August 05, 2021 | News

TFDA approves NaviFUS® therapy system to treat brain tumors

NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan Food and Drug Administr...

August 04, 2021 | News

Understanding the Pandemic Stress Level in Singapore

Stress is an inevitable part of our lives. And when adding a pandemic to the mix, that stress can become an ever-present part of everyday life. H...

August 02, 2021 | News

COVID-19 Associated With Long-Term Cognitive Dysfunction, Acceleration Of Alzheimer's Symptoms

However, questions remain about the long-term impact of the virus on our bodies and brains. New research reported at the Alzheimer's Association Inter...

July 30, 2021 | News

Optical Imaging Facilitates Key Neurological Disease Research

Despite vast amounts of research into neurological diseases, most cannot be cured and only some have therapeutics available. These treatments either slow d...

July 29, 2021 | News

Hyundai Mobis introduces the world first brainwaves based ADAS system, M.Brain.

- The new technology, 'M. Brain' identifies the driver's state through brainwaves and reduces accidents caused by drowsy driving or negligence. - Will tes...

July 22, 2021 | News

Japan has surpassed itself again with the development of ultra-high-concentration lutein

According to the World Report on Vision published in 2020 by World Health Organization (WHO), the incidence of most eye diseases and visual impairments var...

July 14, 2021 | News

ADDI Announces Results of Inaugural Data Challenge

The challenge is a key part of our aim to end Alzheimer’s disease and related dementias by promoting open science and harnessing the power of collabo...

July 05, 2021 | News

Alterity Therapeutics granted a new US patent

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...

July 02, 2021 | News

Fighting Alzheimer’s disease with single cell research: Understanding selective neuronal vulnerability

Watching someone you love lose their precious memories, independence, and sense of self as Alzheimer’s disease (AD) claims their mind is heartbreakin...

June 22, 2021 | Opinion | By Leidamarie Tirado-Lee

Digital therapy services for neuropsychiatric illnesses are a priority in Korea.

KT Corporation and NeuroSigma, Inc. jointly announced signing of a memorandum of understanding, forming a strategic partnership to develop and commercializ...

June 15, 2021 | News

AAS : Next Steps For New Alzheimer's Treatment

Additionally, the FDA appropriately took into account the vast unmet need of the Alzheimer's community. Aduhelm is certainly not a cure, but at long last i...

June 14, 2021 | News

Stay Connected